Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain

BackgroundAlzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and frequently co-occurs with chronic pain. Worldwide, over 55 million people are affected by AD, with nearly half experiencing persistent pain. Chronic pain has been linked to accelerat...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Ivona Costachescu, Raluca-Maria Gogu, Gabriela-Dumitrita Stanciu, Carmen Solcan, Loredana Horodincu, Andrei Szilagyi, Vlad-Constantin Craciun, Daniela-Carmen Ababei, Bogdan-Ionel Tamba
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2026-02-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	Alzheimer’s disease Cannabis sativa L. chronic intermittent therapy comorbidities EU-GMP certification shared neurobiological mechanisms
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1761426/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!